Pilot Study of Casdatifan-Treated Refractory Renal Cell Carcinoma
Clinical trial NCT07748988 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07748988
- Sponsor
- Vanderbilt-Ingram Cancer Center
- Status
- NOT_YET_RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2029-07-01
- Primary completion
- 2030-07-01
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.